SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the Guggenheim 2nd Annual Healthcare Innovation Conference, taking place November 10–12, 2025 in Boston.
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Seeking Alpha / 4 hours ago 1 Views
Comments